Berecek K H, Shier D N
Clin Exp Hypertens A. 1986;8(7):1081-106. doi: 10.3109/10641968609045476.
We have previously demonstrated that chronic intracerebroventricular (ICV) administration of captopril attenuates the development of hypertension in young SHR in association with a depression in whole animal reactivity to vasoactive agents and an increased baroreflex sensitivity. In the present study we analyzed vascular reactivity in perfused kidneys from SHR treated with captopril or vehicle to determine whether the depression in reactivity was due to changes in baroreflex activity or an effect on the vasculature. Captopril (1.25 micrograms/hr) was infused (osmotic mini pumps) for 4 weeks. Vascular reactivity to norepinephrine, angiotensin and vasopressin was assessed in isolated kidneys perfused with an artificial medium at constant flow. SHR treated with ICV captopril showed a significantly lower arterial pressure and basal renal vascular resistance than SHR treated with ICV vehicle or IV captopril. In addition, these rats showed decreased vascular reactivity to all vasoactive agents tested as signified by a shift in the dose-response curves to the right with an increase in threshold (ED16) and ED50. Kidneys from WKY treated with ICV captopril also showed a decrease in vascular reactivity in comparison to WKY treated with ICV vehicle. Our data suggest that captopril, through a central action, attenuates the development of hypertension by decreasing vascular reactivity to vasoconstrictors.
我们先前已证明,慢性脑室内(ICV)给予卡托普利可减轻年轻自发性高血压大鼠(SHR)的高血压发展,这与全动物对血管活性药物的反应性降低及压力感受性反射敏感性增加有关。在本研究中,我们分析了用卡托普利或赋形剂处理的SHR灌注肾中的血管反应性,以确定反应性降低是由于压力感受性反射活动的变化还是对血管系统的影响。用渗透微型泵以1.25微克/小时的速度输注卡托普利4周。在以恒定流量用人工培养基灌注的离体肾脏中评估对去甲肾上腺素、血管紧张素和血管加压素的血管反应性。与用ICV赋形剂或静脉注射卡托普利处理的SHR相比,用ICV卡托普利处理的SHR的动脉压和基础肾血管阻力显著降低。此外,这些大鼠对所有测试的血管活性药物的血管反应性均降低,表现为剂量反应曲线右移,阈值(ED16)和ED50增加。与用ICV赋形剂处理的WKY相比,用ICV卡托普利处理的WKY的肾脏血管反应性也降低。我们的数据表明,卡托普利通过中枢作用,通过降低血管对血管收缩剂的反应性来减轻高血压的发展。